Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000092328.66882.F5PMID 12933536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-density lipoproteins and atherosclerosis.

  2002cited by this paper
• Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation*

  2002cited by this paper
• Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes.

  2001cited by this paper
• Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor.

  2001cited by this paper
• Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I

  2001cited by this paper
• HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

  2001cited by this paper
• Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II

  2001cited by this paper
• The isoprostanes in biology and medicine.

  2001cited by this paper
• ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.

  2000cited by this paper
• Roles of Scavenger Receptor Bi and APO A-I in Selective Uptake of Hdl Cholesterol by Adrenal Cells

  2000cited by this paper
• Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

  1999cited by this paper
• Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

  1998cited by this paper
• ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.

  1998cited by this paper
• Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.

  1997cited by this paper
• Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

  1997cited by this paper
• Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.

  1997cited by this paper
• HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.

  1996cited by this paper
• Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.

  1996cited by this paper
• Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

  1996cited by this paper
• HDL Apolipoprotein A-I Attenuates Oxidative Modification of Low Density Lipoprotein: Studies in Transgenic Mice

  1995cited by this paper
• A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease.

  1995cited by this paper
• Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

  1994cited by this paper
• Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease

  1994cited by this paper
• A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas.

  1994cited by this paper
• Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles.

  1993cited by this paper
• Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.

  1993cited by this paper
• Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

  1993cited by this paper
• Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease.

  1992cited by this paper
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.

  1992cited by this paper
• Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene.

  1991cited by this paper
• A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

  1991cited by this paper
• Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins.

  1991cited by this paper
• Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11.

  1989cited by this paper
• Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

  1988cited by this paper
• DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis.

  1987cited by this paper
• Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol.

  1986cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper
• Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins.

  1985cited by this paper
• Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.

  1983cited by this paper
• High-density lipoproteins and atherosclerosis.

  1982cited by this paper
• Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.

  1982cited by this paper
• Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease.

  1982cited by this paper
• High density lipoproteins and atherosclerosis.

  1980cited by this paper

• Apolipoprotein A1 deficiency increases macrophage apoptosis and necrotic core development in atherosclerotic plaques in a Bim-dependent manner

  2025cites this paper
• Usp21 Knockout Causes Abnormal Lipid Metabolism in Mouse and Its Polymorphism Correlates with Hypercholesterolemia in Outpatients

  2025cites this paper
• Scavenger receptor class B type I knockout mice develop extensive diet-induced coronary artery atherosclerosis in an age-dependent manner

  2025cites this paper
• Association of High apoB/apoA1 Ratio with Increased Erythrocytes, Platelet/Lymphocyte Ratio, D-dimer, Uric Acid and Cardiac Remodeling in Elderly Heart Failure Patients: A Retrospective Study

  2024cites this paper
• Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk

  2023cites this paper
• Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages

  2022cites this paper
• ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future

  2022cites this paper
• HDL and Diabetes.

  2022cites this paper
• Apolipoprotein A1 deficiency in mice primes bone marrow stem cells for T cell lymphopoiesis

  2021cites this paper
• Research methods for animal models of atherosclerosis

  2021cites this paper
• Reciprocal association of serum Mac-2 binding protein and HDL-cholesterol concentrations.

  2021cites this paper
• Mouse models of atherosclerosis and their suitability for the study of myocardial infarction

  2020cites this paper
• Nucleic Acid–Based Therapies for Atherosclerosis

  2020cites this paper
• ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice

  2019cites this paper
• La myéloperoxydase : biomarqueur diagnostique de l'accident vasculaire cérébral ischémique ?

  2019cites this paper
• The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-κB Activation

  2019cites this paper
• Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

  2019cites this paper
• Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.

  2019cites this paper
• Lymphatic system identification, pathophysiology and therapy in the cardiovascular diseases.

  2019cites this paper
• Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?

  2018cites this paper
• 1 Liver – intestine CREBH regulates systemic glucose 2 and lipid metabolism 3

  2018cites this paper
• CREBH Regulates Systemic Glucose and Lipid Metabolism

  2018cites this paper
• HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

  2018cites this paper
• Effet protecteur des HDL en phase aiguë d’AVC ischémique en condition d’hyperglycémie

  2018influential citation
• Interplay between cigarette smoking and pulmonary reverse lipid transport

  2017cites this paper
• Role of LCAT and Apo A-I in Newly Diagnosed HIV Patients

  2017cites this paper
• Detrimental Effect of Hypercholesterolemia on High-Density Lipoprotein Particle Remodeling in Pigs.

  2017cites this paper
• The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

  2017cites this paper
• The ApoM/S1P-complex: its role in vascular inflammatory disease and interaction with S1P-receptors

  2016cites this paper
• Aerobic exercise training protects against endothelial dysfunction by increasing nitric oxide and hydrogen peroxide production in LDL receptor-deficient mice

  2016cites this paper
• Using Mendelian Randomization Studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine

  2016cites this paper
• Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr−/− Mice

  2016cites this paper
• A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.

  2015cites this paper
• Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice

  2015cites this paper
• The role of the lymphatic system in cholesterol transport

  2015cites this paper
• ApoA-I-Directed Therapies for the Management of Atherosclerosis

  2015cites this paper
• ApoA-I mimetics.

  2015cites this paper
• Mouse models of disturbed HDL metabolism.

  2015cites this paper
• High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides.

  2015cites this paper
• Excessive centrifugal fields damage high density lipoprotein[S]

  2015cites this paper
• Study of anti-inflammatory functions of HDL in experimental mouse models

  2015cites this paper
• The Autotransporter Protease EspP: Crystal Structure of the Passenger Domain and Relation to Clot Formation and Stability in Human Blood

  2014cites this paper
• Mendelian Disorders of High-Density Lipoprotein Metabolism

  2014cites this paper
• Polymorphisms of Mouse Apolipoprotein A-II Alter Its Physical and Functional Nature

  2014cites this paper
• Mining the genome for lipid genes.

  2014cites this paper
• The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.

  2014cites this paper
• Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects

  2014cites this paper
• Apolipoprotein A-I Protection Against Atherosclerosis Is Dependent on Genetic Background

  2014cites this paper
• Genetic association with low concentrations of high density lipoprotein-cholesterol in a pediatric population of the Middle East and North Africa: the CASPIAN-III study.

  2014cites this paper
• Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• Increased acylation stimulating protein levels in young obese males is correlated with systemic markers of oxidative stress

  2013cites this paper
• Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children.

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease

  2012cites this paper
• Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

  2012cites this paper
• Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.

  2012cites this paper
• Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.

  2012cites this paper
• Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet

  2012cites this paper
• Lecithin:Cholesterol Acyltransferase Deficiency Protects against Cholesterol-induced Hepatic Endoplasmic Reticulum Stress in Mice*

  2012cites this paper
• The cardiovascular profile of HIV-infected South Africans of African descent: a 5-year prospective study

  2011cites this paper
• Impaired Biologic Activities

  2011cites this paper
• Total cholesterol content of erythrocyte membranes in acute coronary syndrome: correlation with apolipoprotein A-I and lipoprotein (a)

  2011cites this paper
• Apolipoprotein A-I mimetic peptides

  2010cites this paper
• Low Clusterin Levels in High-Density Lipoprotein Associate With Insulin Resistance, Obesity, and Dyslipoproteinemia

  2010cites this paper
• Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies

  2010cites this paper
• The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

  2010cites this paper
• Sequence Variation in the APOA1 and APOA4 Genes and their Relationship with Plasma HDL-Cholesterol Levels

  2009cites this paper
• MESSENGER RNA EXPRESSION OF THE ABCA3 TRANSPORTER AND VASCULAR NITRITE DISTRIBUTION IN RAT AORTA AFTER TREATMENT WITH GLYCERYL TRINITRATE

  2009cites this paper
• HDL therapy for the treatment of cardiovascular diseases.

  2009cites this paper
• The potential role of monocyte-lymphocyte interaction in arteriogenesis

  2009cites this paper
• Genetics and molecular biology: so, so complex HDLs!

  2009cites this paper
• The effects of cholesterol ester transfer protein inhibition on cholesterol efflux.

  2009cites this paper
• Improving cardiovascular disease prevention : from risk assessment to novel therapy

  2009cites this paper
• Models to study atherosclerosis: a mechanistic insight.

  2009influential citation
• HDL: bridging past and present with a look at the future

  2008cites this paper
• Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins

  2008cites this paper
• HIV infection and high density lipoprotein metabolism.

  2008cites this paper
• Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency1 Published, JLR Papers in Press, November 8, 2007.

  2008cites this paper
• A role for CD 44 in atherosclerosis ? Studies in mice and humans

  2008cites this paper
• The value of HDL genetics

  2008cites this paper
• QUE INTERVENEN A L'ESTRUCTURA I METABOLISME DE L'HDL: APOA-II, CETP, ABCA-1 I ABCG5-G8

  2008cites this paper
• Avaluació del Transport Revers de Colesterol Específic de Macròfags

  2008cites this paper
• Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance? Published, JLR Papers in Press, October 28, 2006.

  2007cites this paper
• Increased Protein Nitration Burden in the Atherosclerotic Lesions and Plasma of Apolipoprotein A-I–Deficient Mice

  2007cites this paper
• Overview of murine atherosclerosis series.

  2007cites this paper
• Diet effects on atherosclerosis in mice.

  2007cites this paper
• Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis.

  2007cites this paper
• HDL in Health and Disease: Effects of Exercise and HIV Infection on HDL Metabolism

  2007cites this paper
• Inflammation and skin cholesterol in LDLr 2 / 2 , apoA-I 2 / 2 mice : link between cholesterol homeostasis and self-tolerance ?

  2006cites this paper
• Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.

  2006cites this paper
• Anti-Inflammatory and Antioxidant Functions of High Density Lipoproteins

  2006cites this paper
• Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice.

  2006cites this paper
• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

  2006cites this paper
• Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport.

  2006cites this paper
• Getz and Reardon Diet and Murine Atherosclerois

  2006cites this paper
• Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency Published, JLR Papers in Press, February 23, 2006.

  2006cites this paper
• Inherited disorders of HDL metabolism and atherosclerosis

  2005cites this paper
• Apolipoprotein A-I Mimetic Peptides for the Treatment of Coronary Artery Disease

  2005cites this paper
• ABCA1 and atherosclerosis

  2005cites this paper